Company research
Veradigm Inc.
CIK 1124804Updated Sep 24, 2026
SecurityMDRX · OTC · equity
Name history
ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. · through Dec 12, 2022ALLSCRIPTS-MISYS HEALTHCARE SOLUTIONS, INC. · through Aug 24, 2010ALLSCRIPTS HEALTHCARE SOLUTIONS INC · through Oct 10, 2008ALLSCRIPTS HOLDING INC · through Jan 12, 2001
MDRX price & chart
Loading TradingView…
OTC:MDRX on TradingView ↗About the company
Veradigm has a proven history of delivering clinical and revenue cycle solutions that help independent practices improve outcomes and financial performance. Our AI-forward data and technology also help over 20,000 provider practices connect with health plans and biopharma to eliminate inefficiencies, close care gaps, and create a more affordable health system. © 2026 Veradigm LLC and/or its affiliates. All rights reserved. Cited marks are the property of Veradigm LLC and/or its affiliates. All other product or Company names are the property of their respective holders, all rights reserved.
In the news
No coverage from other publishers is available.
Recent filings
Regulation FD Disclosure
Items 7.01, 9.01
Other Events
Items 8.01
Regulation FD Disclosure
Items 7.01, 9.01
Regulation FD Disclosure
Items 7.01, 9.01
NT 10-Q filing
Show 5 more recent filings
Other Events
Items 8.01, 9.01
4 filing
4 filing
4 filing
4 filing
Financials
FY 2024 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 1,515,615,000Source | 1,572,876,000Source | 1,504,722,000Source | 2,425,229,000Source |
| Property, Plant and Equipment, NetUSD | — | 5,439,000Source | 9,460,000Source | 47,902,000Source |
| GoodwillUSD | 520,701,000Source | 532,494,000Source | 532,640,000Source | 974,478,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 98,325,000Source | 75,057,000Source | 89,333,000Source | 235,930,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 343,501,000Source | 446,601,000Source | 446,593,000Source | 188,351,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 110,919,000Source | 111,161,000Source | 119,147,000Source | 327,069,000Source |
| Assets, CurrentUSD | 606,759,000Source | 699,183,000Source | 679,648,000Source | 761,342,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 67,960,000Source | 54,127,000Source | 56,031,000Source | 118,942,000Source |
| Operating Lease, Right-of-Use AssetUSD | — | 9,138,000Source | 11,979,000Source | 68,909,000Source |
| Other Assets, NoncurrentUSD | 35,514,000Source | 31,687,000Source | 69,398,000Source | 101,160,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 565,648,000Source | 498,435,000Source | 487,217,000Source | 1,017,091,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 2,814,000Source | 2,812,000Source | 2,794,000Source | 2,766,000Source |
| Retained Earnings (Accumulated Deficit)USD | 566,107,000Source | 694,987,000Source | 645,810,000Source | 767,556,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -261,000Source | -90,000Source | -74,000Source | -2,765,000Source |
| Stockholders' Equity Attributable to ParentUSD | 949,974,000Source | 1,074,441,000Source | 1,017,505,000Source | 1,408,138,000Source |
| Additional Paid in Capital, Common StockUSD | 1,932,729,000Source | 1,928,147,000Source | 1,925,205,000Source | 1,962,386,000Source |
| Liabilities and EquityUSD | 1,515,615,000Source | 1,572,876,000Source | 1,504,722,000Source | 2,425,229,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 502,074,000Source | 445,975,000Source | 230,313,000Source | 547,082,000Source |
| Operating Lease, Liability, CurrentUSD | — | 3,478,000Source | 6,608,000Source | 19,599,000Source |
| Accounts Payable, CurrentUSD | 58,684,000Source | 21,276,000Source | 30,841,000Source | 16,836,000Source |
| Operating Lease, Liability, NoncurrentUSD | — | 8,861,000Source | 12,440,000Source | 64,822,000Source |
| Deferred Income Tax Liabilities, NetUSD | — | 0Source | 0Source | 16,625,000Source |
| Other Liabilities, NoncurrentUSD | 63,574,000Source | 52,460,000Source | 44,069,000Source | 34,093,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | -7,000Source | 0Source | — | — |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 57,712,000Source | 52,032,000Source | 66,827,000Source | 92,525,000Source |
| Deferred Revenue, NoncurrentUSD | — | — | 0Source | — |
| Deferred Tax Liabilities, NetUSD | — | — | — | 10,018,000Source |
| Long-term Debt, Current MaturitiesUSD | 218,496,000Source | 205,175,000Source | — | — |
| Long-term Debt, Excluding Current MaturitiesUSD | 0Source | 0Source | 200,395,000Source | 350,062,000Source |
cash flow · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -291,579,000Source | 49,177,000Source | -86,462,000Source | 134,438,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 45,776,000Source | 52,627,000Source | 115,921,000Source | 176,137,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 24,523,000Source | 16,248,000Source | 25,117,000Source | 35,169,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 13,526,000Source | 41,777,000Source | -9,549,000Source | 5,002,000Source |
| Increase (Decrease) in Accounts PayableUSD | 8,891,000Source | -9,499,000Source | 27,870,000Source | -18,729,000Source |
| Deferred Income Tax Expense (Benefit)USD | 67,623,000Source | -28,765,000Source | -65,019,000Source | 2,167,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -20,025,000Source | 99,509,000Source | 115,562,000Source | -75,428,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | 107,259,000Source | -10,000Source | 31,988,000Source | 0Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -125,671,000Source | -88,332,000Source | 585,146,000Source | -12,175,000Source |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | — | — | — | 0Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 1,552,000Source | 2,182,000Source | 2,062,000Source | 5,295,000Source |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 3,187,000Source | 10,643,000Source | 32,129,000Source | 14,023,000Source |
| Payments for Repurchase of Common StockUSD | 0Source | 0Source | 234,425,000Source | 417,443,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -6,652,000Source | -12,476,000Source | -444,911,000Source | -258,866,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -152,348,000Source | -1,299,000Source | 256,249,000Source | -346,945,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 447,900,000Source | 190,520,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 2,169,000Source | 1,860,000Source | — | — |
| Income Taxes Paid, NetUSD | 14,325,000Source | 18,860,000Source | 46,818,000Source | 330,473,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 0Source | 0Source | 452,000Source | -476,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 24,523,000Source | 16,248,000Source | 29,636,000Source | 43,563,000Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | 12,298,000Source | 1,831,000Source | — | — |
| Amortization of Intangible AssetsUSD | 15,406,000Source | 14,272,000Source | 67,669,000Source | 50,552,000Source |
| Capitalized Computer Software, AmortizationUSD | 28,100,000Source | 32,300,000Source | 36,051,000Source | 91,258,000Source |
| Deconsolidation, Revaluation of Retained Investment, Gain (Loss), AmountUSD | — | — | 4,413,000Source | — |
| Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual AmountUSD | 600,000Source | 4,400,000Source | — | — |
| Gain (Loss) on Disposition of BusinessUSD | — | — | 0Source | 8,370,000Source |
| Gain (Loss) on Sale of DerivativesUSD | — | — | — | 0Source |
| Gain (Loss) on Extinguishment of DebtUSD | -17,632,000Source | 0Source | — | — |
| GoodwillUSD | 520,701,000Source | 532,494,000Source | 532,640,000Source | 974,478,000Source |
| Goodwill and Intangible Asset ImpairmentUSD | 108,218,000Source | 179,000Source | — | — |
| Goodwill, Impairment LossUSD | 102,300,000Source | — | — | 0Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | 5,716,000Source | 0Source | — | — |
| Impairment of Intangible Assets, Finite-livedUSD | 5,700,000Source | — | — | — |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | -291,579,000Source | 49,177,000Source | -20,044,000Source | — |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | -284,404,000Source | 49,477,000Source | -20,044,000Source | 133,975,000Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | 0Source | 0Source | -66,418,000Source | 463,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | -7,175,000Source | -300,000Source | -1,143,000Source | 1,757,000Source |
| Income (Loss) from Equity Method Investments, Net of Dividends or DistributionsUSD | — | — | 1,796,000Source | — |
| Income Tax Expense (Benefit)USD | 69,492,000Source | 10,681,000Source | -43,807,000Source | 27,851,000Source |
| Investment Income, InterestUSD | 16,231,000Source | 21,470,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -291,542,000Source | 49,177,000Source | — | — |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | -37,000Source | 0Source | — | 0Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -291,542,000Source | 49,177,000Source | -86,462,000Source | 134,438,000Source |
| Other Nonoperating Income (Expense)USD | -8,230,000Source | -593,000Source | -21,676,000Source | 87,666,000Source |
| Payments to Acquire InvestmentsUSD | 14,094,000Source | 74,118,000Source | 9,933,000Source | 2,421,000Source |
| Provision for Loan, Lease, and Other LossesUSD | 15,333,000Source | 19,001,000Source | — | — |
| Unrealized Gain (Loss) on InvestmentsUSD | -2,700,000Source | -900,000Source | — | — |
income statement · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Total RevenueUSD | 594,410,000Source | 625,984,000Source | 588,017,000Source | 1,503,037,000Source |
| Cost of Goods and Services Sold | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | 269,406,000Source | 200,927,000Source | 169,201,000Source | 313,814,000Source |
| Operating Income (Loss)USD | -194,661,000Source | 34,669,000Source | -27,103,000Source | 77,199,000Source |
| Other Nonoperating Income (Expense)USD | -8,230,000Source | -593,000Source | -21,676,000Source | 87,666,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -214,912,000Source | 60,158,000Source | -63,851,000Source | 161,826,000Source |
| Income Tax Expense (Benefit)USD | 69,492,000Source | 10,681,000Source | -43,807,000Source | 27,851,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | -37,000Source | 0Source | — | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -291,542,000Source | 49,177,000Source | — | — |
| Earnings Per Share, BasicUSD per share | -2.7Source | 0.46Source | -0.77Source | 1.03Source |
| Earnings Per Share, DilutedUSD per share | -2.7Source | 0.41Source | -0.77Source | 0.97Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 108,174,000Source | 107,383,000Source | 112,079,000Source | 130,140,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 108,174,000Source | 124,620,000Source | 112,079,000Source | 138,658,000Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 15,406,000Source | 14,272,000Source | 67,669,000Source | 50,552,000Source |
| Business Combination, Acquisition Related CostsUSD | — | — | 500,000Source | — |
| Capitalized Computer Software, AmortizationUSD | 28,100,000Source | 32,300,000Source | 36,051,000Source | 91,258,000Source |
| Current Income Tax Expense (Benefit)USD | 1,869,000Source | 39,446,000Source | 21,212,000Source | 25,684,000Source |
| Deconsolidation, Revaluation of Retained Investment, Gain (Loss), AmountUSD | — | — | 4,413,000Source | — |
| Depreciation, Depletion and Amortization, NonproductionUSD | 2,300,000Source | 6,100,000Source | 9,896,000Source | 26,847,000Source |
| Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual AmountUSD | 600,000Source | 4,400,000Source | — | — |
| Goodwill, Impairment LossUSD | 102,300,000Source | — | — | 0Source |
| Gross ProfitUSD | 302,245,000Source | 341,507,000Source | 308,420,000Source | 619,565,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | -291,579,000Source | 49,177,000Source | -20,044,000Source | — |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -218,003,000Source | 56,044,000Source | -64,783,000Source | 141,367,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | -284,404,000Source | 49,477,000Source | -20,044,000Source | 133,975,000Source |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | -2.7Source | 0.46Source | -0.18Source | 1.03Source |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | -2.7Source | 0.41Source | -0.18Source | 0.97Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | 0Source | 0Source | -66,418,000Source | 463,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | -7,175,000Source | -300,000Source | -1,143,000Source | 1,757,000Source |
| Interest ExpenseUSD | 15,045,000Source | 5,294,000Source | 6,354,000Source | 13,166,000Source |
| Interest Income (Expense), Nonoperating, NetUSD | — | — | 4,901,000Source | — |
| Investment Income, InterestUSD | 16,231,000Source | 21,470,000Source | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -291,542,000Source | 49,177,000Source | -86,462,000Source | 134,438,000Source |
| Net Income (Loss) from Continuing Operations Available to Common Shareholders, BasicUSD | -291,542,000Source | 49,177,000Source | — | 133,975,000Source |
| Research and Development ExpenseUSD | 108,255,000Source | 96,993,000Source | 97,889,000Source | 193,671,000Source |
Filing attachments
mdrx-ex99_1.htm · 8-K · 2026-09-15
EX-99.1 2 mdrx-ex99_1.htm EX-99.1 Investor Deck September 2026 VDMT-2697-AUG-2026 Exhibit 99.1 Disclaimer and Forward-Looking Statement Information This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, without limitation, statements regarding the Company’s preliminary estimated unaudited 2025 financial information, the Company's anticipated revenue growth and future financial performance, the Company's bu…
Read attachment ↗mdrx-ex99_1.htm · 8-K · 2026-09-08
EX-99.1 2 mdrx-ex99_1.htm EX-99.1 EX-99.1 Exh. 99.1 Veradigm Announces Updated Presentation Time for Upcoming Investor Conference September 08, 2026 CHICAGO--(BUSINESS WIRE) - September 8, 2026 -- Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that it will now present at the 2026 Jefferies Healthcare Services and Technology Conference on September 15th at 3:35PM CT. A live webcast of the fireside chat will …
Read attachment ↗mdrx-ex99_1.htm · 8-K · 2026-08-17
EX-99.1 2 mdrx-ex99_1.htm EX-99.1 EX-99.1 Exh. 99.1 Veradigm to Participate in Two Upcoming Investor Conferences August 17, 2026 CHICAGO--(BUSINESS WIRE)--August 17, 2026 -- Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that management will be participating in the following investor conferences in September. 2026 Jefferies Healthcare Services and Technology Conference (Nashville, September 15, 2026) Don …
Read attachment ↗mdrx-ex99_1.htm · 8-K · 2026-05-26
EX-99.1 2 mdrx-ex99_1.htm EXH. 99.1 EX-99.1 Exhibit 99.1 Veradigm Files 2023 and 2024 Form 10-K Reaches Major SEC Filing Milestone; Now Advancing 2025 and 2026 Filings CHICAGO - May 26, 2026 - Veradigm ® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today the filing of its comprehensive Annual Report on Form 10-K for the years ended December 31, 2023 and 2024 (the “2023 and 2024 Form 10-K”) with the Securities and Exchang…
Read attachment ↗d69521dex991.htm · 8-K · 2026-04-06
EX-99.1 5 d69521dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Veradigm Appoints Christian Greyenbuhl as Chief Financial Officer CHICAGO - April 6, 2026 - Veradigm Inc. (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced the appointment of Christian Greyenbuhl as Chief Financial Officer of the Company, effective on the later of May 11, 2026 and the first business day after Veradigm files its Annual Report on Form 10-K for its 2023 and …
Read attachment ↗mdrx-ex99_1.htm · 8-K · 2026-02-17
EX-99.1 2 mdrx-ex99_1.htm EXH. 99.1 EX-99.1 Exhibit 99.1 Veradigm Provides Business and Strategy Update CHICAGO - February 17, 2026 - Veradigm ® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, is providing estimated financial performance for the fiscal year 2025 and key areas of strategic focus for 2026. “On my first investor call in October, I committed to advancing three strategic objectives in my first 100 days: reset our business…
Read attachment ↗